HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Cited by other online articles Google Scholar Articles by Carter, C. S. Articles by Sonntag, W. E. Articles citing this Article PubMed PubMed Citation Articles by Carter, C. S. Articles by Sonntag, W. E.

Models of Growth Hormone and IGF-1 Deficiency

Applications to Studies of Aging Processes and Life-Span Determination

^a Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
^b Department of Internal Medicine, University of Vermont School of Medicine, Burlington

William E. Sonntag, Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157-1083 E-mail: wsonntag{at}wfubmc.edu.

Decision Editor: John A. Faulkner, PhD

The remarkable progress in understanding the genetic basis of life-span determination in invertebrates indicates that impairments in the insulin–insulin-like growth factor 1 (IGF-1) signaling cascade increase longevity. Similarities among insulin and IGF-1-like signaling pathways in invertebrates and mammals raise the possibility that modifications of these pathways may extend life span in mammals. Investigators using Ames, Snell, and growth hormone receptor knockout models have concluded that decreased growth hormone and IGF-1 are responsible for increased life span. In this review, we critique the dwarf models and, based on multiple endocrine deficiencies and developmental anomalies, conclude that these models may not be sufficient to assess the consequences of growth hormone or IGF-1 deficiency on either biological aging or life span. We attempt to resolve some of these issues by presenting an alternative animal model of growth hormone–IGF-1 deficiency. Finally, we propose an integrated explanation of growth hormone and IGF-1's contribution to the aging phenotype and life-span determination.

This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)

				W. E. Sonntag, C. Bennett, R. Ingram, A. Donahue, J. Ingraham, H. Chen, T. Moore, J. K. Brunso-Bechtold, and D. Riddle Growth hormone and IGF-I modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E604 - E610. [Abstract] [Full Text] [PDF]

				A J van der Lely Justified and unjustified use of growth hormone Postgrad. Med. J., October 1, 2004; 80(948): 577 - 580. [Abstract] [Full Text] [PDF]

				D. Kipling, T. Davis, E. L. Ostler, and R. G. A. Faragher What Can Progeroid Syndromes Tell Us About Human Aging? Science, September 3, 2004; 305(5689): 1426 - 1431. [Abstract] [Full Text] [PDF]

				M. Barbieri, M. Bonafe, C. Franceschi, and G. Paolisso Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1064 - E1071. [Abstract] [Full Text] [PDF]

				C. S. Carter, W. E. Sonntag, G. Onder, and M. Pahor Physical Performance and Longevity in Aged Rats J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2002; 57(5): B193 - 197. [Abstract] [Full Text]